These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB. Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877 [TBL] [Abstract][Full Text] [Related]
4. [Cladribine]. Ogura M Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885 [TBL] [Abstract][Full Text] [Related]
5. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review). Van den Neste E; Cardoen S; Offner F; Bontemps F Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330 [TBL] [Abstract][Full Text] [Related]
6. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line. Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241 [TBL] [Abstract][Full Text] [Related]
7. The influence of 2-chloro-2'-deoxyadenosine on metabolism of deoxyadenosine in human primary CNS lymphoma. Fabianowska-Majewska K; Tybor K; Duley J; Simmonds A Biochem Pharmacol; 1995 Oct; 50(9):1379-83. PubMed ID: 7503787 [TBL] [Abstract][Full Text] [Related]
8. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies. Saven A; Piro LD Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205 [TBL] [Abstract][Full Text] [Related]
9. New purine analogues for the treatment of chronic B-cell malignancies. Gribbin TE Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757 [TBL] [Abstract][Full Text] [Related]
10. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases. Spiers AS Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies. Saven A Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757 [No Abstract] [Full Text] [Related]
12. Cladribine: from the bench to the bedside--focus on hairy cell leukemia. Greyz N; Saven A Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of pentostatin and cladribine in hairy cell leukemia. Johnston JB Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108 [TBL] [Abstract][Full Text] [Related]
14. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues. Pettitt AR; Sherrington PD; Cawley JC Cancer Res; 2000 Aug; 60(15):4187-93. PubMed ID: 10945628 [TBL] [Abstract][Full Text] [Related]
17. Adverse and beneficial immunological effects of purine nucleoside analogues. Dighiero G Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S75-81. PubMed ID: 9137960 [TBL] [Abstract][Full Text] [Related]
18. Cladribine. Ortho Biotech Inc. Tortorella C; Rovaris M; Filippi M Curr Opin Investig Drugs; 2001 Dec; 2(12):1751-6. PubMed ID: 11892941 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of the ERK pathway promotes apoptosis induced by 2-chloro-2'-deoxyadenosine in the B-cell leukemia cell line EHEB. Smal C; Lisart S; Ferrant A; Bontemps F; van den Neste E Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1009-12. PubMed ID: 17065055 [TBL] [Abstract][Full Text] [Related]
20. Cladribine: not just another purine analogue? Spurgeon S; Yu M; Phillips JD; Epner EM Expert Opin Investig Drugs; 2009 Aug; 18(8):1169-81. PubMed ID: 19604118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]